Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Suspended × Brentuximab Vedotin × Clear all

Phase

Status

Completed 66 Active not recruiting 16 Terminated 15 Recruiting 14 Withdrawn 11 Unknown 11 Not yet recruiting 2 Suspended 1 No longer available 1 Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

Specimen Handling 31 Magnetic Resonance Spectroscopy 21 Cyclophosphamide 17 Biopsy 16 Vincristine 9 Nivolumab 9 Doxorubicin 9 Cisplatin 9 Prednisone 8 Paclitaxel 8 Bevacizumab 8 Gemcitabine 7 pembrolizumab 6 Rituximab 6 Etoposide 6 Drug Therapy 6 Docetaxel 6 Carboplatin 6 Radiotherapy 5 Radiosurgery 5 Fluorouracil 5 Capecitabine 5 venetoclax 4 prednylidene 4 fludarabine 4 durvalumab 4 deltacortene 4 atezolizumab 4 S 1 (combination) 4 Radiation 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03187210 2025-03-30

BAL

Insel Gruppe AG, University Hospital Bern

Phase 1/2 Suspended

Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡